Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 26 2015

Print

Breaking News

Related Searches:
December 17, 2010
Commercial manufacturing revenues were flat at $144.8 million in the quarter.  Read More »
December 17, 2010
3M Drug Delivery Systems has signed an exclusive license agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products.   Read More »
December 17, 2010
David Duffield, director of Global Security for Catalent Pharma Solutions has been awarded membership in the American Society for Industrial Security (ASIS), Pharmaceutical Security Council.   Read More »
December 16, 2010
Aesica Pharmaceuticals has entered agreements to acquire three manufacturing sites from UCB, in Monheim and Zwickau, Germany, and Pianezza, Italy.  Read More »
December 16, 2010
Catalyst Biosciences, Inc. has received a $4.0 million milestone payment from Pfizer under their collaboration agreement for the development of recombinant human Factor VIIa variants for the treatment of hemophilia and other bleeding disorders.   Read More »
December 16, 2010
GlaxoSmithKline and Impax Pharmaceuticals entered an agreement for the development and commercialization of IPX066, Impax’s extended release carbidopa-levodopa product, outside the U.S. and Taiwan.  Read More »
December 16, 2010
Galapagos has achieved a $4.7 million milestone in its strategic alliance with Roche.   Read More »
December 15, 2010
Alcon, Inc. has approved a merger agreement with Novartis AG, under which Novartis will pay $12.9 billion for all outstanding Alcon shares.  Read More »
December 15, 2010
Ian Read, Pfizer’s new chief executive officer, has made changes to the company’s executive team.  Read More »
December 15, 2010
Anthera Pharmaceuticals has selected the Merck BioManufacturing Network to manufacture the large-scale GMP clinical and pre-commercial supplies of A-623, an investigational peptibody in development for autoimmune diseases.  Read More »
December 15, 2010
DSM Pharmaceutical Products has entered a license agreement with c-LEcta GmbH for its alcohol dehydrogenases screening technology for enzyme screening programs and development of sustainable manufacturing routes for pharmaceutical active ingredients and i  Read More »
December 14, 2010
Charles River Laboratories International, Inc. released its business outlook, highlighting its portfolio and its plan to focus on four key initiatives in an effort to drive shareholder value.  Read More »
December 14, 2010
Kathleen P. Bloch has been appointed chief financial officer of Laureate Pharma.   Read More »
December 14, 2010
INC Research, LLC has moved its headquarters into new offices in Raleigh, NC.  Read More »
December 13, 2010
Sartorius Stedim Systems GmbH, a subsidiary of Sartorius Stedim Biotech (SSB), is expanding its capacity and optimizing its production operations by combining its work and production areas.  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On